Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Assessment of Progression of Paroxysmal Atrial Fibrillation in Patients After Coronary Artery Bypass Grafting Through Continuous Subcutaneous Monitoring

NCT02246803 is registered in ClinicalTrials.gov with Meshalkin Research Institute of Pathology of Circulation as lead sponsor.

NCT NCT02246803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02246803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Assessment of Progression of Paroxysmal Atrial Fibrillation in Patients After Coronary Artery Bypass Grafting Through Continuous Subcutaneous Monitoring
Lead sponsor
Meshalkin Research Institute of Pathology of Circulation
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2014
Completion date
December 31, 2017
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation, coronary artery disease